Fundamental Analysis
48 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -2.6% | +12.6% | 2 / 3 | -5.9% | -1.92 pp | +1.61 pp | +17.4% | 0.76 | 5.77 | 451 | −5,9% | 24,0 | +34,9% | 5.77 | 15.94 | −63,8% |
| Pts | 0 | 0 | 8 | 0 | 4 | 8 | 8 | 12 | 12 | |||||||
Valuation annotation:Price: 14.000 (close price on 2026-10-19)EPS (TTM): 2.425
Financial charts
1.Revenue & growth
VND bn451Q2/26
1.Revenue & growth
VND bn451Q2/26
2.Profit & growth
VND bn25,3Q2/26
3.Profit mix (Penman)
VND bn61,2Q2/26
4.Margins & cost structure
%12.5%Q2/26
5.Returns & cash cycle
% · days14.1%Q2/26
6.Earnings quality & cash
VND bn154Q2/26
7.Asset structure
VND bn742Q2/26
8.Funding & debt health
VND bn · times742Q2/26
9.Revenue backlog
VND bn13,4Q2/26
10.Valuation
times · %6,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.399Q2/26
Adjusted EPS growth, latest quarter
18.7%
Average adjusted EPS growth, 3 quarters
12.4%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
Share history could not be reconciled
Source: vnstockData through Q2/26